Bone effects of rosiglitazone in HIV-infected patients with lipoatrophy.

Ross, Allison C; Hileman, Corrilynn O; Brown, Todd T; Fedarko, Neal; Storer, Norma; Labbato, Danielle; McComsey, Grace A

Ross, Allison C; Hileman, Corrilynn O; Brown, Todd T; Fedarko, Neal; Storer, Norma; Labbato, Danielle; McComsey, Grace A.

Affiliation

Ross AC; Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia 30322, USA. across3@emory.edu

HIV Clin Trials ; 13(4): 212-21, 2012.

Article in En | MEDLINE | ID: mdl-22849962

Subject(s)

Bone and Bones/drug effects; Diabetes Mellitus, Lipoatrophic/drug therapy; HIV Infections/complications; Hypoglycemic Agents/adverse effects; Thiazolidinediones/adverse effects; Adult; Bone Density/drug effects; Bone and Bones/metabolism; Collagen Type I/blood; Double-Blind Method; Female; Humans; Male; Middle Aged; Multivariate Analysis; Osteocalcin/blood; Peptides/blood; Rosiglitazone

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone and Bones / HIV Infections / Thiazolidinediones / Diabetes Mellitus, Lipoatrophic / Hypoglycemic Agents Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: HIV Clin Trials Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) / TERAPEUTICA Year: 2012 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google